| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-05 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.19 | 8e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |